This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Conjunctivitis (chlamydia)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

This usually presents with generalised hyperaemia and profuse mucopurulent discharge. Itching is minimal.

The two principal forms are:

  • inclusion conjunctivitis - in young sexually active adults - or in the infant - chlamydial ophthalmia neonatorum
  • trachoma - principally a disease of the underdeveloped world
    • most common infectious cause of blindness (1)
    • caused by ocular serovars of Chlamydia trachomatis

Less often, chlamydia infection may present with conjunctivitis in psittacosis and lymphogranuloma venerum.

Chlamydia conjunctivitis is treated, in adults, with topical chlortetracycline ointment, applied three or four times per day, and a single 1 gram dose of azithromycin (2).

Reference:

  1. Mabey DC et al. Trachoma. Lancet. 2003 Jul 19;362(9379):223-9.
  2. Stamm WE et al. Azithromycin for empirical treatment of nongonococcal urethritis syndrome in men. A randomized doubleblind study. JAMA 1995; 274: 5459.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.